Momenta Pharmaceuticals, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was USD 5.182 million compared to USD 13.031 million a year ago. Operating loss was USD 116.626 million compared to USD 70.840 million a year ago. Net loss was USD 113.969 million compared to USD 69.885 million a year ago. Basic loss per share was USD 1.16 compared to USD 0.91 a year ago. For the half year, total revenue was USD 9.295 million compared to USD 17.883 million a year ago. Operating loss was USD 164.717 million compared to USD 119.842 million a year ago. Net loss was USD 158.812 million compared to USD 117.516 million a year ago. Basic loss per share was USD 1.61 compared to USD 1.55 a year ago.